Condition: Malignant Neoplasm · Sponsor: Merck Sharp & Dohme LLC
Researchers are looking for new ways to treat certain advanced or metastatic solid tumors. The goal of this study is to learn about the safety of MK-4716 and if people tolerate it when taken alone or with other treatments.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Rutgers Cancer Institute of New Jersey ( Site 0052) | New Brunswick, New Jersey, United States | Recruiting |
| NEXT Oncology ( Site 0051) | Irving, Texas, United States | Recruiting |
| NEXT Virginia ( Site 0054) | Fairfax, Virginia, United States | Recruiting |
| Blacktown Hospital ( Site 0455) | Sydney, New South Wales, Australia | Recruiting |
| Monash Health ( Site 0452) | Clayton, Victoria, Australia | Recruiting |
| The Alfred Hospital ( Site 0453) | Melbourne, Victoria, Australia | Recruiting |
| One Clinical Research ( Site 0454) | Nedlands, Western Australia, Australia | Recruiting |
| Princess Margaret Cancer Centre ( Site 0001) | Toronto, Ontario, Canada | Recruiting |
| Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0002) | Québec, Quebec, Canada | Recruiting |
| Pontificia Universidad Catolica de Chile-CICUC ( Site 0103) | Santiago, Region M. de Santiago, Chile | Recruiting |
| Bradfordhill ( Site 0102) | Santiago, Region M. de Santiago, Chile | Recruiting |
| Rambam Health Care Campus ( Site 0252) | Haifa, Israel | Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07247110